02 May 2003 : Case report
Systemic administration of the PARP-1 inhibitor GPI 15427 increases the anti-tumor activity of temozolomide against metastatic melanoma
Med Sci Monit 2003; 9(1): 69-0 :: ID: 15212
Metrics
Views & Downloads
Views: 806
Downloads: 0
Maximum downloads: 0 (